Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in January

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. Excluding different doses and formulations, more than 140 brands of drugs will…

Read More